Cargando…
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
The Krebs cycle-derived metabolite itaconate is highly upregulated in inflammatory macrophages and exerts immunomodulatory effects through cysteine modifications on target proteins. The NLRP3 inflammasome, which cleaves IL-1β, IL-18, and gasdermin D, must be tightly regulated to avoid excessive infl...
Autores principales: | Hooftman, Alexander, Angiari, Stefano, Hester, Svenja, Corcoran, Sarah E., Runtsch, Marah C., Ling, Chris, Ruzek, Melanie C., Slivka, Peter F., McGettrick, Anne F., Banahan, Kathy, Hughes, Mark M., Irvine, Alan D., Fischer, Roman, O’Neill, Luke A.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422798/ https://www.ncbi.nlm.nih.gov/pubmed/32791101 http://dx.doi.org/10.1016/j.cmet.2020.07.016 |
Ejemplares similares
-
Itaconate confers tolerance to late NLRP3 inflammasome activation
por: Bambouskova, Monika, et al.
Publicado: (2021) -
Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophages
por: Hoyle, Christopher, et al.
Publicado: (2022) -
Itaconate Suppresses the Activation of Mitochondrial NLRP3 Inflammasome and Oxidative Stress in Allergic Airway Inflammation
por: Xie, Qiu-Meng, et al.
Publicado: (2023) -
Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?
por: Hooftman, Alexander, et al.
Publicado: (2021) -
Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis
por: Kuo, Ping-Chang, et al.
Publicado: (2020)